Agilent Acquires Lab901 to Bolster Electrophoresis Play; Will Evaluate Potential Dx Apps

Lab901's automated benchtop gel electrophoresis system and associated consumables are expected to complement Agilent's existing commercial offerings for gel electrophoresis. Lab901 also has a fledgling multiplex PCR-based diagnostic business that Agilent will review in coming weeks.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.